Skip to main content
. 2026 Jun 15;16(6):1003. doi: 10.3390/life16061003
ALD Advanced liver disease
APTT Activated partial thromboplastin time
CLD Chronic liver disease
DOACs Direct oral anticoagulants
INR International normalized ratio
LMWHs Low molecular weight heparins
NAFLD Non-alcoholic fatty liver disease
PT Prothrombin time
PVT Portal vein thrombosis
ROTEM Rotational thromboelastometry
TEG Thromboelastography
TIPS Transjugular intrahepatic portosystemic shunt
UGIB Upper gastrointestinal bleeding
VKAs Vitamin K antagonists
vWF von Willebrand factor